Diabetes Type 1
Conditions
Keywords
stress, voice markers, glycemic control
Brief summary
Stress refers to all the reactions of an organism subjected to exogenous or endogenous stress. In the context of diabetes, stress plays a critical role. There are two forms of stress: acute and chronic, both of which can have a significant impact on patients' glycaemic control. Acute stress, if repeated, can cause rapid increases in blood glucose levels, while chronic stress can lead to insulin resistance. It is therefore essential to develop tools for recognising and quantifying stress states specific to patients with diabetes. These tools would provide a better understanding of the role of stress in diabetes management, paving the way for more targeted therapeutic interventions and improving patients' quality of life. We are currently training algorithms using advanced machine learning and artificial intelligence techniques to recognise and quantify stress states using existing databases, including voice and physiological data. These technological advances will make it possible to identify moments of stress more accurately and provide appropriate responses, thereby contributing to better diabetes management. The SMART-T1D study is an ancillary study of the EVASTRESS study.
Interventions
OTHERVoice recording 4 times a day
* Morning (first recording): Text reading (article 25.1 of the Declaration of Human Rights). * Noon (second recording): Counting from 1 to 20 at normal speed * Evening (third recording): Prolonged phonation of the vowel 'a' without catching your breath. * Bedtime (fourth recording): Free expression describing stressful moments of the day and their impact on diabetes management, for at least 30 seconds.
Sponsors
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient who has signed the SMART-T1D free and informed consent form * Patient able to speak and read French
Exclusion criteria
* Mute patient. * Patient with severe speech problems that may prevent voice recordings from being made.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Voice recording of participants | 14 days | Daily voice recordings |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Diabetes-related distress in the test population | at inclusion and after 14 days | DDS T1 is an indicator of overall diabetes distress (average of 17 items, rated 1 to 6 on a scale). A higher score indicates higher distress. |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORPierre-Yves Benhamou, Pr
University Hospital, Grenoble
Outcome results
None listed